COCH: Envoy Medical Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Envoy Medical Inc (COCH).
$28.95M Market Cap.
COCH Market Cap. (MRY)
COCH Shares Outstanding (MRY)
COCH Assets (MRY)
Total Assets
$11.54M
Total Liabilities
$30.38M
Total Investments
$0
COCH Income (MRY)
Revenue
$225.00K
Net Income
-$20.80M
Operating Expense
$18.74M
COCH Cash Flow (MRY)
CF Operations
-$17.95M
CF Investing
-$980.00K
CF Financing
$20.20M
COCH Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $11,538,000 (39.50%) | $8,271,000 (223.59%) | $2,556,000 (-2.59%) | $2,624,000 |
Assets Current | $9,384,000 (25.86%) | $7,456,000 (352.43%) | $1,648,000 (-32.35%) | $2,436,000 |
Assets Non-Current | $2,154,000 (164.29%) | $815,000 (-10.24%) | $908,000 (382.98%) | $188,000 |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Shareholders Equity | -$18,842,000 (-960.92%) | -$1,776,000 (95.09%) | -$36,195,000 (19.50%) | -$44,960,000 |
Property Plant & Equipment Net | $2,154,000 (164.29%) | $815,000 (-10.24%) | $908,000 (382.98%) | $188,000 |
Cash & Equivalents | $5,483,000 (29.99%) | $4,218,000 (2204.92%) | $183,000 (-83.68%) | $1,121,000 |
Accumulated Other Comprehensive Income | -$123,000 (-4.24%) | -$118,000 (-2.61%) | -$115,000 (-6.48%) | -$108,000 |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Inventory | $1,708,000 (21.65%) | $1,404,000 (8.42%) | $1,295,000 (22.17%) | $1,060,000 |
Trade & Non-Trade Receivables | $818,000 (232.52%) | $246,000 (500.00%) | $41,000 (-53.41%) | $88,000 |
Trade & Non-Trade Payables | $1,652,000 (6.31%) | $1,554,000 (54.94%) | $1,003,000 (51.74%) | $661,000 |
Accumulated Retained Earnings (Deficit) | -$284,734,000 (-10.68%) | -$257,256,000 (-13.84%) | -$225,985,000 (-7.58%) | -$210,062,000 |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Total Debt | $19,661,000 (3398.40%) | $562,000 (-98.37%) | $34,535,000 (47.10%) | $23,477,000 |
Debt Current | $143,000 (-9.49%) | $158,000 (-72.43%) | $573,000 (0%) | $0 |
Debt Non-Current | $19,518,000 (4731.19%) | $404,000 (-98.81%) | $33,962,000 (44.66%) | $23,477,000 |
Total Liabilities | $30,380,000 (202.38%) | $10,047,000 (-74.07%) | $38,751,000 (40.35%) | $27,611,000 |
Liabilities Current | $7,538,000 (3.47%) | $7,285,000 (189.20%) | $2,519,000 (82.01%) | $1,384,000 |
Liabilities Non-Current | $22,842,000 (727.01%) | $2,762,000 (-92.38%) | $36,232,000 (38.15%) | $26,227,000 |
COCH Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $225,000 (-28.80%) | $316,000 (33.33%) | $237,000 (-23.55%) | $310,000 |
Cost of Revenue | $742,000 (-5.96%) | $789,000 (58.43%) | $498,000 (-35.24%) | $769,000 |
Selling General & Administrative Expense | $8,560,000 (-4.14%) | $8,930,000 (157.35%) | $3,470,000 (40.32%) | $2,473,000 |
Research & Development Expense | $10,179,000 (13.66%) | $8,956,000 (80.02%) | $4,975,000 (26.30%) | $3,939,000 |
Operating Expenses | $18,739,000 (4.77%) | $17,886,000 (111.79%) | $8,445,000 (31.71%) | $6,412,000 |
Interest Expense | $816,000 (0%) | $0 (0%) | $0 (0%) | $0 |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Consolidated Income | -$20,795,000 (30.50%) | -$29,922,000 (-87.92%) | -$15,923,000 (-83.55%) | -$8,675,000 |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Income | -$20,795,000 (30.50%) | -$29,922,000 (-87.92%) | -$15,923,000 (-83.55%) | -$8,675,000 |
Preferred Dividends Income Statement Impact | $7,178,000 (432.10%) | $1,349,000 (0%) | $0 (0%) | $2,000,000 |
Net Income Common Stock | -$27,973,000 (10.55%) | -$31,271,000 (-96.39%) | -$15,923,000 (-49.16%) | -$10,675,000 |
Weighted Average Shares | $18,790,448 (52.83%) | $12,295,391 (21.46%) | $10,123,169 (-92.73%) | $139,219,864 |
Weighted Average Shares Diluted | $18,790,448 (52.83%) | $12,295,391 (21.46%) | $10,123,169 (-92.73%) | $139,219,864 |
Earning Before Interest & Taxes (EBIT) | -$19,979,000 (33.23%) | -$29,922,000 (-87.92%) | -$15,923,000 (-83.55%) | -$8,675,000 |
Gross Profit | -$517,000 (-9.30%) | -$473,000 (-81.23%) | -$261,000 (43.14%) | -$459,000 |
Operating Income | -$19,256,000 (-4.89%) | -$18,359,000 (-110.88%) | -$8,706,000 (-26.71%) | -$6,871,000 |
COCH Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$980,000 (-540.52%) | -$153,000 (29.82%) | -$218,000 (-74.40%) | -$125,000 |
Net Cash Flow from Financing | $20,198,000 (-5.09%) | $21,282,000 (163.00%) | $8,092,000 (0.42%) | $8,058,000 |
Net Cash Flow from Operations | -$17,949,000 (-5.02%) | -$17,091,000 (-94.11%) | -$8,805,000 (-26.95%) | -$6,936,000 |
Net Cash Flow / Change in Cash & Cash Equivalents | $1,265,000 (-68.65%) | $4,035,000 (530.17%) | -$938,000 (-195.04%) | $987,000 |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Capital Expenditure | -$980,000 (-540.52%) | -$153,000 (29.82%) | -$218,000 (-74.40%) | -$125,000 |
Issuance (Repayment) of Debt Securities | $19,084,000 (102.23%) | $9,437,000 (17.96%) | $8,000,000 (0.00%) | $8,000,000 |
Issuance (Purchase) of Equity Shares | $3,561,000 (-69.94%) | $11,845,000 (0%) | $0 (0%) | $0 |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Effect of Exchange Rate Changes on Cash | -$5,000 (-66.67%) | -$3,000 (57.14%) | -$7,000 (30.00%) | -$10,000 |
Share Based Compensation | $562,000 (-64.32%) | $1,575,000 (0%) | $0 (0%) | $0 |
Depreciation Amortization & Accretion | $173,000 (30.08%) | $133,000 (77.33%) | $75,000 (5.63%) | $71,000 |
COCH Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | -229.80% (-53.51%) | -149.70% (-35.97%) | -110.10% (25.66%) | -148.10% |
Profit Margin | -12432.40% (-25.63%) | -9895.90% (-47.29%) | -6718.60% (-95.11%) | -3443.50% |
EBITDA Margin | -8802.70% (6.62%) | -9426.90% (-40.98%) | -6686.90% (-140.93%) | -2775.50% |
Return on Average Equity (ROAE) | 195.70% (50.08%) | 130.40% (103.12%) | 64.20% (1.90%) | 63.00% |
Return on Average Assets (ROAA) | -309.50% (-92.96%) | -160.40% (-3108.00%) | -5.00% (-51.52%) | -3.30% |
Return on Sales (ROS) | -8879.60% (6.22%) | -9469.00% (-40.94%) | -6718.60% (-140.09%) | -2798.40% |
Return on Invested Capital (ROIC) | -215.40% (-49.58%) | -144.00% (-2838.78%) | -4.90% (-81.48%) | -2.70% |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% |
Price to Earnings Ratio (P/E) | -0.96 (-34.64%) | -0.71 (88.83%) | -6.38 (94.76%) | -121.75 |
Price to Sales Ratio (P/S) | 119.42 (69.52%) | 70.45 (-83.54%) | 427.99 (-90.22%) | 4,374.21 |
Price to Book Ratio (P/B) | -1.54 (92.29%) | -19.93 (-35.52%) | -14.71 (-27.79%) | -11.51 |
Debt to Equity Ratio (D/E) | -1.61 (71.50%) | -5.66 (-428.20%) | -1.07 (-74.43%) | -0.61 |
Earnings Per Share (EPS) | -1.49 (41.34%) | -2.54 (-61.78%) | -1.57 (-1862.50%) | -0.08 |
Sales Per Share (SPS) | 0.01 (-53.85%) | 0.03 (13.04%) | 0.02 (1050.00%) | 0 |
Free Cash Flow Per Share (FCFPS) | -1.01 (28.17%) | -1.4 (-57.35%) | -0.89 (-1647.06%) | -0.05 |
Book Value Per Share (BVPS) | -1 (-596.53%) | -0.14 (95.97%) | -3.58 (-1006.81%) | -0.32 |
Tangible Assets Book Value Per Share (TABVPS) | 0.61 (-8.77%) | 0.67 (167.06%) | 0.25 (1226.32%) | 0.02 |
Enterprise Value Over EBIT (EV/EBIT) | -2 (-100.00%) | -1 (97.06%) | -34 (43.33%) | -60 |
Enterprise Value Over EBITDA (EV/EBITDA) | -2.03 (-215.09%) | -0.64 (98.09%) | -33.66 (43.91%) | -60.02 |
Asset Turnover | 0.03 (56.25%) | 0.02 (1500.00%) | 0 (0.00%) | 0 |
Current Ratio | 1.25 (21.70%) | 1.02 (56.42%) | 0.65 (-62.84%) | 1.76 |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 |
Free Cash Flow (FCF) | -$18,929,000 (-9.77%) | -$17,244,000 (-91.11%) | -$9,023,000 (-27.79%) | -$7,061,000 |
Enterprise Value (EV) | $40,135,157 (109.62%) | $19,146,197 (-96.41%) | $533,510,503 (3.31%) | $516,405,485 |
Earnings Before Tax (EBT) | -$20,795,000 (30.50%) | -$29,922,000 (-87.92%) | -$15,923,000 (-83.55%) | -$8,675,000 |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$19,806,000 (33.51%) | -$29,789,000 (-87.97%) | -$15,848,000 (-84.19%) | -$8,604,000 |
Invested Capital | $18,178,000 (780.82%) | -$2,670,000 (-107.76%) | $34,389,000 (45.74%) | $23,596,000 |
Working Capital | $1,846,000 (979.53%) | $171,000 (119.63%) | -$871,000 (-182.79%) | $1,052,000 |
Tangible Asset Value | $11,538,000 (39.50%) | $8,271,000 (223.59%) | $2,556,000 (-2.59%) | $2,624,000 |
Market Capitalization | $28,950,157 (-18.21%) | $35,397,197 (-93.35%) | $532,312,500 (2.87%) | $517,437,500 |
Average Equity | -$14,292,750 (40.38%) | -$23,972,954 (3.38%) | -$24,812,644 (-46.55%) | -$16,931,016 |
Average Assets | $9,038,000 (-53.65%) | $19,500,072 (-93.92%) | $320,968,314 (0.25%) | $320,179,288 |
Invested Capital Average | $9,275,500 (-55.36%) | $20,777,434 (-93.62%) | $325,811,036 (0.77%) | $323,305,791 |
Shares | 20,244,865 (3.55%) | 19,549,982 (-63.20%) | 53,125,000 (0.00%) | 53,125,000 |